Abstract:Organismal aging has been associated with diverse metabolic and functional changes across tissues. Within the immune system, key features of physiological hematopoietic cell aging include increased fat deposition in the bone marrow, impaired hematopoietic stem and progenitor cell (HSPC) function, and a propensity towards myeloid differentiation. This shift in lineage bias can lead to pre-malignant bone marrow conditions such as clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenias of undetermined significance (CCUS), frequently setting the stage for subsequent development of age-related cancers in myeloid or lymphoid lineages. At the systemic as well as sub-cellular level, human aging has also been associated with diverse lipid alterations, such as decreased phospholipid membrane fluidity that arises as a result of increased saturated fatty acid (FA) accumulation and a decay in n-3 polyunsaturated fatty acid (PUFA) species by the age of 80 years, however the extent to which impaired FA metabolism contributes to hematopoietic aging is less clear. Here, we performed comprehensive multi-omics analyses and uncovered a role for a key PUFA biosynthesis gene, , in mouse and human immune cell aging. Whole transcriptome RNA-sequencing studies of bone marrow from aged mutant (enzyme-deficient) mice compared with age-matched controls revealed global down-regulation in lymphoid cell markers and expression of genes involved specifically in B cell development. Flow cytometric analyses of immune cell markers confirmed an aging-associated loss of B cell markers that was exacerbated in the bone marrow of mutant mice and unveiled CD79B, a vital molecular regulator of lymphoid progenitor development from the pro-B to pre-B cell stage, as a putative surface biomarker of accelerated immune aging. Complementary lipidomic studies extended these findings to reveal select alterations in lipid species in aged and mutant mouse bone marrow samples, suggesting significant changes in the biophysical properties of cellular membranes. Furthermore, single cell RNA-seq analysis of human HSPCs across the spectrum of human development and aging uncovered a rare subpopulation (<7%) of CD34+ HSPCs that expresses in healthy adult bone marrow. This HSPC subset, along with -expressing lymphoid-committed cells, were almost completely absent in CD34+ cells isolated from elderly (>60 years old) bone marrow samples. Together, these findings uncover new roles for lipid metabolism enzymes in the molecular regulation of cellular aging and immune cell function in mouse and human hematopoiesis. In addition, because systemic loss of ELOVL2 enzymatic activity resulted in down-regulation of B cell genes that are also associated with lymphoproliferative neoplasms, this study sheds light on an intriguing metabolic pathway that could be leveraged in future studies as a novel therapeutic modality to target blood cancers or other age-related conditions involving the B cell lineage.

Alterations of the Systemic Environment Are the Primary Cause of Impaired B and T Lymphopoiesis in Telomere-Dysfunctional Mice.

Telomere Dysfunction Induces Environmental Alterations Limiting Hematopoietic Stem Cell Function and Engraftment

Telomere dysfunctional environment induces loss of quiescence and inherent impairments of hematopoietic stem cell function (vol 11, pg 449, 2012)

Longevity, stress response, and cancer in aging telomerase-deficient mice

Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status.

Alterations of Systemic Environment Impair Stem Cell Function during Aging

Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development

Telomere length, stem cells and aging

The aged tumor microenvironment limits T cell control of cancer

Telomere Dysfunction and Cell Cycle Checkpoints in Hematopoietic Stem Cell Aging

B Cells Promote T Cell Immunosenescence and Mammalian Aging Parameters

The aged microenvironment impairs BCL6 and CD40L induction in CD4+ T follicular helper cell differentiation

Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

An aged immune system drives senescence and ageing of solid organs

Age-Associated Changes to Lymph Node Fibroblastic Reticular Cells

Telomere Dysfunction and Stem Cell Ageing

Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Thymic microenvironment's impact on immunosenescence

Age-Related Alterations in the Lymphohematopoietic and B-Lineage Precursor Populations in Nzb Mice